Lennon David James, Chief Executive Officer of Whitehawk Therapeutics, Inc. ($WHWK), made one open market sale of common shares in the last 365 days, totaling $16,879. His most recent sale occurred on March 2, 2026. These sales rank 11,115th among 11,678 insiders in the database, where the average sale amount is $8.6 million across about 6.4 transactions per insider. He had no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Units | 775828 | $0.00 | 0.0000 | 69,204,899 | 100.00% | 1.12% |
| April 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 831148 | $0.00 | 831,148.0000 | 69,204,899 | 9999.99% | 1.20% |
| April 2, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | S | Common Stock | 26858 | $3.48 | 793,549.0000 | 69,204,899 | 3.27% | 0.04% |
| April 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | M | Common Stock | 775828 | $0.00 | 820,407.0000 | 69,204,899 | 1740.34% | 1.12% |
| March 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | M | Common Stock | 16250 | $0.00 | 49,679.0000 | 69,204,899 | 48.61% | 0.02% |
| March 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Units | 16250 | $0.00 | 32,500.0000 | 69,204,899 | 33.33% | 0.02% |
| March 2, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | S | Common Stock | 5100 | $3.31 | 44,579.0000 | 69,204,899 | 10.27% | 0.01% |
| April 1, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 775828 | $0.00 | 775,828.0000 | 27,029,942 | 9999.99% | 2.87% |
| April 1, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Units | 775828 | $0.00 | 775,828.0000 | 27,029,942 | 9999.99% | 2.87% |
| March 1, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Units | 16250 | $0.00 | 48,750.0000 | 27,029,942 | 25.00% | 0.06% |
| March 1, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | M | Common Stock | 16250 | $0.00 | 39,119.0000 | 27,029,942 | 71.06% | 0.06% |
| March 3, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | S | Common Stock | 5690 | $2.35 | 33,429.0000 | 27,029,942 | 14.55% | 0.02% |
| Oct. 2, 2024 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Units | 32558 | $0.00 | 0.0000 | 27,041,327 | 100.00% | 0.12% |
| Oct. 3, 2024 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | S | Common Stock | 9689 | $1.94 | 22,869.0000 | 27,041,327 | 29.76% | 0.04% |
| Oct. 2, 2024 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | M | Common Stock | 32558 | $0.00 | 32,558.0000 | 27,041,327 | 9999.99% | 0.12% |
| March 1, 2024 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Units | 65000 | $0.00 | 65,000.0000 | 26,917,967 | 9999.99% | 0.24% |
| March 1, 2024 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | A | Stock option (right to buy) | 30768 | $0.00 | 30,768.0000 | 26,917,967 | 9999.99% | 0.11% |
| March 1, 2024 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 26,917,967 | 9999.99% | 0.48% |
| Oct. 2, 2023 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | Chief Executive Officer | A | Restricted Stock Units | 32558 | $0.00 | 32,558.0000 | 0 | 9999.99% | 0.00% |
| Oct. 2, 2023 | Whitehawk Therapeutics, Inc. | $WHWK | Lennon David James | Chief Executive Officer | A | Stock Option (right to buy) | 490000 | $0.00 | 490,000.0000 | 0 | 9999.99% | 0.00% |